MIRA INFORM REPORT

 

 

Report No. :

306531

Report Date :

05.02.2015

 

IDENTIFICATION DETAILS

 

Name :

HEMMO PHARMACEUTICALS PRIVATE LIMITED (w.e.f. 21.02.2008)

 

 

Formerly Known As :

JASHAN TEXTITLE MILLS PRIVATE LIMITED

 

 

Registered Office :

113, 114 and 115, Turf Estate, 3/65, Off Dr. E. Moses Road, Mahalaxmi, Mumbai – 400011, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

07.11.1979

 

 

Com. Reg. No.:

11-021857

 

 

Capital Investment / Paid-up Capital :

Rs.2.908 Millions

 

 

CIN No.:

[Company Identification No.]

U17100MH1979PTC021857

 

 

TIN No.:

Not Available

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMJ08705E

 

 

PAN No.:

[Permanent Account No.]

AAACJ0958M

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Peptides. 

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (47)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 1520000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record. Overall financial position of the company is decent.

 

Trade relations are reported to be fair. Business is active. Payments are reported to be usually correct.

 

The company can be considered for business dealings at usual trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

LOCATIONS

 

Registered Office/ Corporate Office :

113, 114 and 115, Turf Estate, 3/65, Off Dr. E. Moses Road, Mahalaxmi, Mumbai – 400011, Maharashtra, India 

Tel. No.:

91-22-24946100 / 24949984 / 24949987 / 43546200

Fax No.:

91-22-24946101

E-Mail :

hemmoin@mtnl.net.in 

 

 

Manufacturing Unit :

Plot No.C-43, TTC Industrial Area, MIDC, Off Thane Belapur Road, Pawane – 400613, Maharashtra, India

Tel No.:

91-22-41552000

 

 

Research and Development Unit 1 :

159 – A, Wagle Industrial Estate, 25th Road, MIDC, Thane – 400604, Maharashtra, India

Tel No.:

91-22-41552100

 

 

Research and Development Unit 2 :

Pic De Peguera 11,A0 07, Edifici Giroempren, Parc Cientific de Girona, 17003, Girona, Spain

Tel No.:

+34972183208

Email Id:

j.bacardit@hemmopharma.com

 

 

DIRECTORS

 

As on 30.09.2014

 

Name :

Mr. Madhu Vikram Utamsingh

Designation :

Managing Director

Address :

26, Sonmarg, 67B, Napean Sea Road, Mumbai – 400006, Maharashtra, India

Date of Birth/Age :

30.10.1966

Date of Appointment :

01.10.2012

DIN No.:

00756570

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24200MH1980PTC022986

HEMMO PHARMA PRIVATE LIMITED

Director

30/09/2008

01/08/2008

-

Active

NO

2

U17100MH1979PTC021857

HEMMO PHARMACEUTICALS PRIVATE LIMITED

Managing director

01/10/2012

01/08/2008

-

Active

NO

 

 

Name :

Mr. Jairam Tejumal Hemrajani

Designation :

Managing Director

Address :

203 A, Sky – Scraper, 74 Warden Road, Mumbai – 400026, Maharashtra, India

Date of Birth/Age :

29.08.1929

Date of Appointment :

14.11.1985

DIN No.:

00756381

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24200MH1980PTC022986

HEMMO PHARMA PRIVATE LIMITED

Director

16/08/1980

16/08/1980

-

Active

NO

2

U17100MH1979PTC021857

HEMMO PHARMACEUTICALS PRIVATE LIMITED

Managing director

14/11/1985

14/11/1985

-

Active

NO

3

U25200MH1970PTC014565

CREEK INSULATIONS CHEMICALS PRIVATE LIMITED

Director

31/03/2000

31/03/2000

-

Dormant

NO

 

 

Name :

Mrs. Savita Jairam Hemrajani

Designation :

Director

Address :

203 A, Sky – Scraper, 74 Warden Road, Mumbai – 400026, Maharashtra, India

Date of Birth/Age :

24.05.1937

Date of Appointment :

14.11.1985

DIN No.:

00756488

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24200MH1980PTC022986

HEMMO PHARMA PRIVATE LIMITED

Director

16/08/1980

16/08/1980

-

Active

NO

2

U17100MH1979PTC021857

HEMMO PHARMACEUTICALS PRIVATE LIMITED

Director

14/11/1985

14/11/1985

-

Active

NO

3

U25200MH1970PTC014565

CREEK INSULATIONS CHEMICALS PRIVATE LIMITED

Director

16/08/2002

16/08/2002

-

Dormant

NO

 

 

Name :

Mrs. Rekha Jairam Hemrajani

Designation :

Director

Address :

213 A, Sky – Scraper, 74 Warden Road, Mumbai – 400026, Maharashtra, India

Date of Birth/Age :

08.05.1969

Date of Appointment :

01.07.1991

DIN No.:

01985764

 

 

MAJOR SHAREHOLDERS

 

As on 30.09.2014

 

Names of Shareholders

 

No. of Shares

Jairam Tejumal Hemrajani (Held on Behalf of Hemmo Pharma Private Limited, India)

 

200

Hemmo Pharma Private Limited, India

 

19675

Savita Jairam Hemrajani (Held on Behalf of Hemmo Pharma Private Limited, India )

 

200

Madhu Vikram Utamsingh

 

6000

Rekha Jairam Hemrajani

 

3000

Total

 

29075

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.09.2014

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

10.00

Bodies corporate

68.00

Directors or relatives of Directors

22.00

Total

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Peptides. 

 

 

Products :

Product Description

Item Code No. (ITC Code)

Peptides

2937.1900

Peptides

3003.3900

 

 

Brand Names :

--

 

 

Agencies Held :

--

 

 

Exports :

Not Available

 

 

Imports :

Not Available

 

 

Terms :

 

Selling :

Not Available

 

 

Purchasing :

Not Available

 

PRODUCTION STATUS – NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Available

Name of the Person :

Not Available

Contact No.:

Not Available

Since How Long Known :

Not Available

Experience :

Not Available

Maximum Limit Dealt :

Not Available

Remark :

Not Available

 

 

Customers :

Reference :

Not Available

Name of the Person :

Not Available

Contact No.:

Not Available

Since How Long Known :

Not Available

Experience :

Not Available

Maximum Limit Dealt :

Not Available

Remark :

Not Available

 

 

No. of Employees :

Not Available

 

 

Bankers :

  • Indian Overseas Bank, Kalhaderd Branch, Mumbai, Maharashtra, India

Tel No.: 91-22-22404769

  • Oriental Bank of Commerce, Kalhaderd Branch, Mumbai - 400002, Maharashtra, India

 

 

Facilities :

SECURED LOANS

31.03.2014

Rs. In Millions

31.03.2013

Rs. In Millions

LONG TERM BORROWINGS

 

 

Vehicle Loan

 

(Vehicle loan including Rs.0.432 million (previous year Rs.0.388 million) included under other current liabilities] are secured by hypothecation of vehicles financed. The amount outstanding at the end of the year is repayable in 24 equated monthly installments of Rs.0.038 million including interest at 10.94% on monthly reducing bases)

0.000

0.432

SHORT TERM BORROWINGS

 

 

Working Capital Loan from Bank Repayable on Demand

 

 

Bank Overdraft

35.136

49.422

Total

35.136

49.854

 

 

 

Auditors :

 

Name :

P. D. Kunte and Company

Chartered Accountants

Address :

205/206, Turf Estate, Off Dr. E. Moses Road, Mahalaxmi, Mumbai – 400011,  Maharashtra, India

PAN No:

AAAFP3277G

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Sister Concern :

Not Available

 

 

CAPITAL STRUCTURE

 

As on 30.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

50000

Equity Shares

Rs.100/- each

Rs.5.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

29075

Equity Shares

Rs.100/- each

Rs.2.908 Millions

 


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

2.908

2.908

2.908

(b) Reserves & Surplus

527.496

486.262

468.570

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

530.404

489.170

471.478

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.432

0.821

(b) Deferred tax liabilities (Net)

13.218

12.918

9.027

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

1.695

1.463

1.191

Total Non-current Liabilities (3)

14.913

14.813

11.039

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

57.636

52.922

38.963

(b) Trade payables

67.871

50.447

35.620

(c) Other current liabilities

34.451

13.226

16.143

(d) Short-term provisions

6.423

3.373

2.692

Total Current Liabilities (4)

166.381

119.968

93.418

 

 

 

 

TOTAL

711.698

623.951

575.935

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

218.280

219.707

183.531

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

3.241

4.659

52.085

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

185.121

183.749

128.952

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

5.342

6.504

5.408

(e) Other Non-current assets

0.000

0.120

0.000

Total Non-Current Assets

411.984

414.739

369.976

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

1.647

(b) Inventories

85.001

59.357

53.567

(c) Trade receivables

40.459

35.641

39.117

(d) Cash and cash equivalents

118.290

87.244

87.372

(e) Short-term loans and advances

54.952

26.774

23.703

(f) Other current assets

1.012

0.196

0.553

Total Current Assets

299.714

209.212

205.959

 

 

 

 

TOTAL

711.698

623.951

575.935

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

 NA

 NA

221.255

 

 

Other Income

 NA

 NA

24.746

 

 

TOTAL                                    

 NA

 NA

246.001

 

 

 

 

 

 

EXPENSES

 NA

 NA

211.818

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

82.108

53.920

34.183

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                    

30.275

27.391

22.521

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX

51.833

26.529

11.662

 

 

 

 

 

Less

TAX                                                     

10.599

8.837

1.851

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX

41.234

17.692

9.811

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

191.092

173.400

163.589

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

232.326

191.092

173.400

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

287.360

218.510

122.224

 

TOTAL EARNINGS

287.360

218.510

122.224

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

NA

32.689

32.149

 

 

Packing Materials

NA

0.284

0.000

 

 

Consumable Stores

NA

6.611

4.067

 

 

Capital Goods

NA

5.977

4.536

 

TOTAL IMPORTS

NA

45.561

40.752

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

1418.19

608.51

337.43

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT/Sales)

(%)

NA

NA

4.43

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

9.90

6.09

2.95

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.10

0.05

0.02

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.11

0.11

0.08

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.80

1.74

2.20

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Share Capital

2.908

2.908

2.908

Reserves & Surplus

468.570

486.262

527.496

Share Application money pending allotment

0.000

0.000

0.000

Net worth

471.478

489.170

530.404

 

 

 

 

Long Term borrowings

0.821

0.432

0.000

Short Term borrowings

38.963

52.922

57.636

Total borrowings

39.784

53.354

57.636

Debt/Equity ratio

0.084

0.109

0.109

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last one year

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------

22]

Litigations that the firm / promoter involved in

----------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------

26]

Buyer visit details

----------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

UNSECURED LOANS:

 

Particulars

31.03.2014

Rs. In Millions

31.03.2013

Rs. In Millions

SHORT TERM BORROWINGS

 

 

Loan From Directors

22.500

3.500

Total

22.500

3.500

 

 

OPERATIONS

 

Income from operations for the year is higher as compared with the preceding year mainly due to higher turnover (including exports turnover)

 

 

INDEX OF CHARGE:

 

Sr. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

90218208

22/09/1998

320,000.00

Indian Overseas Bank

Kalhaderd Branch, Mumbai, Maharashtra, India

-

2

90217939

18/09/1995

5,000,000.00

Oriental Bank Of Commerce

Kalhaderd Branch, Mumbai, Maharashtra - 400002, India

-

3

90216183

30/06/1997 *

2,000,000.00

Oriental Bank Of Commerce

Kalhaderd Branch, Mumbai, Maharashtra - 400002, India

-

4

90217579

11/12/1993 *

1,500,000.00

Oriental Bank Of Commerce

Kalhaderd Branch, Mumbai, Maharashtra - 400002, India

-

5

90217422

30/07/1990

1,000,000.00

The Sangli Bank Limited

90-92; Vazi Sayed Street, Mandvi, Mumbai, Maharashtra - 400003, India

-

6

90217074

27/10/1989 *

320,000.00

Indian Overseas Bank

Kalbadevi Road Branch, Mumbai, Maharashtra - 400002, India

-

7

90216752

12/07/1981

329,962.00

The Sangli Bank Limited

90-92; Vazi Sayed Street, Mandvi, Mumbai, Maharashtra - 400003, India

-

8

90216707

10/07/1980

160,000.00

The Sangli Bank Limited

90-92; Vazi Sayed Street, Mandvi, Mumbai, Maharashtra - 400003, India

-

*Date of modification Charges

 

 

FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Machinery

·         Computer

·         Vehicles

·         Furniture and Fixture

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.74

UK Pound

1

Rs.92.71

Euro

1

Rs.69.94

 

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

VNT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILITY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

47

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.